Patents by Inventor Hideo Nishimura

Hideo Nishimura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11956238
    Abstract: [Problem] Provided is an authorization system capable of reducing a load on a host regarding an invitation procedure in a case where there is a large number of guests or guests are frequently invited, and preventing identity theft or invitation of an unwanted third party.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: April 9, 2024
    Assignee: Nippon Telegraph and Telephone Corporation
    Inventors: Yoshihiko Omori, Takao Yamashita, Hideo Nishimura
  • Patent number: 11917076
    Abstract: [Problem] To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. [Solution] The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.
    Type: Grant
    Filed: May 25, 2022
    Date of Patent: February 27, 2024
    Assignee: Nippon Telegraph and Telephone Corporation
    Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
  • Publication number: 20230263740
    Abstract: An object of the present invention is to obtain a capsule for treating ulcerative colitis which, when a capsule containing indigo is orally administered, acts more effectively than conventional ones and has less side effects of hepatotoxicity by not easily disintegrating in the stomach and small intestine but only in the large intestine. The present invention relates to a capsule for treating ulcerative colitis which disintegrates locally in the large intestine, comprising a drug-containing content, a protective layer coating the content and a film formed outside the protective layer, which are arranged concentrically, wherein the content is a content in which indigo, which is a drug for treating ulcerative colitis, is dispersed or dissolved, and the film is locally disintegrated in the large intestine.
    Type: Application
    Filed: May 2, 2023
    Publication date: August 24, 2023
    Inventors: Takanori KANAI, Hideo NISHIMURA, Tomoyuki KOYAMA, Takuhiko ADACHI, Hiroyuki HAYAKAWA
  • Patent number: 11595844
    Abstract: A plant system includes: an access node connected to a network; a plurality of controllers configured to perform distributed control on a plurality of field devices provided in a plant; and a wireless communication unit provided in each group of a plurality of groups into which the plurality of controllers are grouped and connected to each controller in the corresponding group via a wired connection, and configured to connect each controller to the access node via a wireless connection.
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: February 28, 2023
    Assignee: Yokogawa Electric Corporation
    Inventor: Hideo Nishimura
  • Patent number: 11483159
    Abstract: [Problem] To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. [Solution] The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: October 25, 2022
    Assignee: Nippon Telegraph and Telephone Corporation
    Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
  • Publication number: 20220286297
    Abstract: To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.
    Type: Application
    Filed: May 25, 2022
    Publication date: September 8, 2022
    Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
  • Publication number: 20220286296
    Abstract: [Problem] To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. [Solution] The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.
    Type: Application
    Filed: May 25, 2022
    Publication date: September 8, 2022
    Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
  • Patent number: 11424915
    Abstract: [Problem] A terminal registration system and a terminal registration method that enable the number of communication operations between terminals to be reduced are provided.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: August 23, 2022
    Assignee: Nippon Telegraph and Telephone Corporation
    Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura
  • Publication number: 20210320924
    Abstract: [Problem] Provided is an authorization system capable of reducing a load on a host regarding an invitation procedure in a case where there is a large number of guests or guests are frequently invited, and preventing identity theft or invitation of an unwanted third party.
    Type: Application
    Filed: August 23, 2019
    Publication date: October 14, 2021
    Inventors: Yoshihiko Omori, Takao Yamashita, Hideo Nishimura
  • Publication number: 20210320790
    Abstract: [Problem] A terminal registration system and a terminal registration method that enable the number of communication operations between terminals to be reduced are provided.
    Type: Application
    Filed: August 1, 2019
    Publication date: October 14, 2021
    Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura
  • Publication number: 20210136621
    Abstract: A plant system includes: an access node connected to a network; a plurality of controllers configured to perform distributed control on a plurality of field devices provided in a plant; and a wireless communication unit provided in each group of a plurality of groups into which the plurality of controllers are grouped and connected to each controller in the corresponding group via a wired connection, and configured to connect each controller to the access node via a wireless connection.
    Type: Application
    Filed: October 5, 2020
    Publication date: May 6, 2021
    Inventor: Hideo NISHIMURA
  • Publication number: 20210058256
    Abstract: [Problem] To provide a terminal registration system and a terminal registration method for improving user convenience in registration of a new terminal to a plurality of service sites. [Solution] The registered terminal 1 includes an Authenticator 10 including service site list information 110 that associates private keys and URLs for access to service sites with each other. A Registration Manager 100 acquires the service site list information 110 from the Authenticator 10 of the registered terminal 1. Then, the Registration Manager 100 performs FIDO authentication for a registration target service site using a private key of the registered terminal 1, on the basis of the acquired service site list information 110, and performs Registration of a newly generated cryptographic key at the new terminal 2.
    Type: Application
    Filed: February 5, 2019
    Publication date: February 25, 2021
    Inventors: Hideo Nishimura, Takao Yamashita, Yasuhiko Yoshimura, Satoru Furukawa
  • Publication number: 20200352868
    Abstract: An object of the present invention is to obtain a capsule for treating ulcerative colitis which, when a capsule containing indigo is orally administered, acts more effectively than conventional ones and has less side effects of hepatotoxicity by not easily disintegrating in the stomach and small intestine but only in the large intestine. The present invention relates to a capsule for treating ulcerative colitis which disintegrates locally in the large intestine, comprising a drug-containing content, a protective layer coating the content and a film formed outside the protective layer, which are arranged concentrically, wherein the content is a content in which indigo, which is a drug for treating ulcerative colitis, is dispersed or dissolved, and the film is locally disintegrated in the large intestine.
    Type: Application
    Filed: January 16, 2019
    Publication date: November 12, 2020
    Inventors: Takanori KANAI, Hideo NISHIMURA, Tomoyuki KOYAMA, Takuhiko ADACHI, Hiroyuki HAYAKAWA
  • Patent number: 8640873
    Abstract: A plastic ampule comprising a body portion, a head portion provided continuously to the mouth portion of the body portion through a cut-off portion, and a knob portion provided continuously to the head portion the ampule being unsealed by twisting the knob portion with fingers to cut the head portion off the mouth portion, wherein the hollow portion in the head portion is formed in the shape of a bowl. Since the hollow portion is formed in the shape of a bowl, content liquid remaining in the hollow portion can be discharged easily, the plastic ampule can be unsealed easily, and the content liquid remaining in the hollow portion is not scattered easily at the time of unsealing.
    Type: Grant
    Filed: April 23, 2009
    Date of Patent: February 4, 2014
    Assignee: Nippon Zoki Pharamaceutical Co., Ltd.
    Inventors: Hideshi Nakano, Hideo Nishimura
  • Patent number: 8580557
    Abstract: The present invention relates to a casein hydrolysate containing free amino acids and in vivo indigestible peptides having minimally suppressed in vivo enzymatic digestibility, and expected to express functions, such as hypotensive effect, in living organism, and to a method for preparing such a hydrolysate, and use thereof. The casein hydrolysate of the present invention contains free amino acids and peptides, such as in vivo indigestible peptides including Xaa-Pro and Xaa-Pro-Pro, obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, and has ACE inhibitory activity or hypotensive effect.
    Type: Grant
    Filed: September 1, 2010
    Date of Patent: November 12, 2013
    Assignee: Calpis Co., Ltd.
    Inventors: Naoyuki Yamamoto, Seiichi Mizuno, Takanobu Gotou, Keiichi Matsuura, Tadashi Shinoda, Hideo Nishimura
  • Publication number: 20110082281
    Abstract: The present invention relates to a casein hydrolysate containing free amino acids and in vivo indigestible peptides having minimally suppressed in vivo enzymatic digestibility, and expected to express functions, such as hypotensive effect, in living organism, and to a method for preparing such a hydrolysate, and use thereof. The casein hydrolysate of the present invention contains free amino acids and peptides, such as in vivo indigestible peptides including Xaa-Pro and Xaa-Pro-Pro, obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, and has ACE inhibitory activity or hypotensive effect.
    Type: Application
    Filed: September 1, 2010
    Publication date: April 7, 2011
    Applicant: CALPIS CO., LTD.
    Inventors: Naoyuki Yamamoto, Seiichi Mizuno, Shingo Nishimura, Hideo Nishimura, Takanobu Gotou, Keiichi Matsuura, Tadashi Shinoda
  • Publication number: 20110031157
    Abstract: A plastic ampule comprising a body portion, a head portion provided continuously to the mouth portion of the body portion through a cut-off portion, and a knob portion provided continuously to the head portion the ampule being unsealed by twisting the knob portion with fingers to cut the head portion off the mouth portion, wherein the hollow portion in the head portion is formed in the shape of a bowl. Since the hollow portion is formed in the shape of a bowl, content liquid remaining in the hollow portion can be discharged easily, the plastic ampule can be unsealed easily, and the content liquid remaining in the hollow portion is not scattered easily at the time of unsealing.
    Type: Application
    Filed: April 23, 2009
    Publication date: February 10, 2011
    Applicant: NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Hideshi Nakano, Hideo Nishimura
  • Publication number: 20070299014
    Abstract: The present invention relates to a casein hydrolysate containing free amino acids and in vivo indigestible peptides having minimally suppressed in vivo enzymatic digestibility, and expected to express functions, such as hypotensive effect, in living organism, and to a method for preparing such a hydrolysate, and use thereof. The casein hydrolysate of the present invention contains free amino acids and peptides, such as in vivo indigestible peptides including Xaa-Pro and Xaa-Pro-Pro, obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, and has ACE inhibitory activity or hypotensive effect.
    Type: Application
    Filed: July 30, 2004
    Publication date: December 27, 2007
    Applicant: CALPIS CO., LTD.
    Inventors: Naoyuki Yamamoto, Seiichi Mizuno, Shingo Nishimura, Hideo Nishimura, Takanobu Gotou, Keiichi Matsuura, Tadashi Shinoda
  • Publication number: 20070122451
    Abstract: The present invention provides novel in vivo indigestible peptides that are highly absorbable and hardly digestible in living organism when administered orally or through other route, and expected to effectively exhibit functions, such as hypotensive effect, in living organism, and ACE inhibitors prepared with the peptides, and medicine or functional food expected to effectively exhibit hypotensive effect in living organism. The in vivo indigestible peptides are dipeptides or tripeptides having Pro at the carboxyl terminals, selected from the group consisting of Ile-Pro, Glu-Pro, Arg-Pro, Gln-Pro, Met-Pro, and Ser-Pro-Pro.
    Type: Application
    Filed: July 30, 2004
    Publication date: May 31, 2007
    Applicant: Calpis Co., Ltd.
    Inventors: Naoyuki Yamamoto, Seiichi Mizuno, Shingo Nishimura, Hideo Nishimura, Takanobu Gotou, Keiichi Matsuura
  • Patent number: 6803398
    Abstract: An olefin-based thermoplastic elastomer composition comprising a thermoplastic elastomer blended with other resins and rubbers is provided. The thermoplastic elastomer contains polypropylene resin and an olefin-based copolymer rubber, and optionally, a linear polyethylene resin, and the thermoplastic elastomer has been crosslinked to a gel content of 95% or higher. A polyolefin resin, an olefin-based copolymer rubber and a softening agent are further blended with optional inorganic filler to provide the olefin-based thermoplastic elastomer composition. This composition is excellent in oil resistance and extrudability, and well-adapted for use as an energy-saving, resources-saving elastomer in applications including surface or skin material in autoparts, industrial mechanical parts, electric and electronic parts, and construction materials.
    Type: Grant
    Filed: February 28, 2000
    Date of Patent: October 12, 2004
    Assignees: Mitsui Chemicals, Inc., Toyota Motor Corporation
    Inventors: Yuichi Ito, Hiroyasu Yamaoka, Akira Uchiyama, Chika Kako, Hideo Nishimura, Junzo Ukai